UBS AM’s PHARMACYCLICS INC PCYC Stock Holding History

UBS AM’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-305,781	Closed	-$78.3M	–	2755
2015 Q1	$78.3M	Sell	305,781 -107,512	-26%	-$20.8M	0.08%	283
2014 Q4	$50.5M	Buy	413,293 +9,665	+2%	+$1.24M	0.05%	411
2014 Q3	$47.4M	Buy	403,628 +11,142	+3%	+$1.27M	0.05%	412
2014 Q2	$35.2M	Buy	392,486 +12,083	+3%	+$1.13M	0.04%	520
2014 Q1	$38.1M	Buy	380,403 +75,330	+25%	+$9.79M	0.04%	468
2013 Q4	$32.3M	Buy	305,073 +76,109	+33%	+$9.24M	0.04%	479
2013 Q3	$31.7M	Buy	228,964 +3,700	+2%	+$411K	0.04%	462
2013 Q2	$17.9M	Buy	+225,264	New	+$18.4M	0.02%	606

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

UBS AM's PCYC Position: Q2 2015 in Review

UBS AM sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 305,781 shares — an estimated $78.3M sold.

UBS AM first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $78.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

UBS AM reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
UBS AM sold 305,781 PHARMACYCLICS INC shares in Q2 2015, an estimated $78.3M.
UBS AM first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
UBS AM's PHARMACYCLICS INC position peaked at $78.3M in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.